There is a tidy story that gets repeated whenever dog cancer comes up: purebreds get it, mutts dodge it, adopt a mixed breed and worry less. A widely cited insurance analysis seemed to prove it. Then a large university study looked at the same question a different way and found something that does not fit the tidy story at all. Put the two side by side and the honest conclusion is not “purebreds are doomed.” It is that the meaningful question was never purebred versus mixed as a category. It is which breed, because that is where the risk actually lives. This piece walks through both studies, why they disagree, and what that leaves you to actually do.
The study that started the story
The insurer Nationwide assembled a team of veterinarians and data scientists to comb through cancer claims filed across its pet division between 2015 and 2021, a dataset of 1.61 million dogs. The headline: purebreds were nearly twice as likely, 1.9 times to be exact, to file a cancer claim as the average dog. With a sample that size drawn from every state and from rural, suburban, and urban practices alike, the number is not easy to wave away.
But there is a caveat baked into how the study was built, and it matters more than it first appears. This was a single-variable analysis. It did not control for the other things that drive cancer risk, such as age, size, obesity, or nutrition. It also counted insurance claims, not confirmed diagnoses across the whole dog population, and purebred owners who buy pet insurance may simply pursue more workups. So the study is real and large, but it measures a correlation with a lot of tangled threads behind it.
A single-variable study can tell you a pattern exists, not why. With 1.6 million dogs behind it, the Nationwide signal is worth respecting, but “purebreds get more cancer” is a headline, not a mechanism.
— Dr. Mara Chen, DVM
The study that complicated it
Here is the part the original coverage missed, and it changes the takeaway. Researchers at UC Davis examined roughly 90,000 dogs and found no greater overall cancer risk for purebred dogs compared with mixed breeds. For several of the cancers people fear most, including osteosarcoma, hemangiosarcoma, mast cell tumors, and lymphoma, the rates came out about the same in purebreds and mixes.
Two large studies, opposite-sounding results. They are not actually contradictory once you see what each is really measuring. “Purebred” is not one genetic thing; it is hundreds of separate gene pools. Averaged together as a single bucket, purebreds do not clearly out-risk mixed breeds. But specific breeds, carrying specific inherited variants concentrated by generations of selective breeding, absolutely do run higher risks for specific cancers. The Nationwide bucket caught that breed-level signal and labeled it “purebred.” The UC Davis approach shows that the category label was the wrong unit all along. Risk is a breed-by-breed map, not a purebred-versus-mutt line.
Where the risk actually clusters
Once you look at breeds instead of the category, the map gets specific and useful. In the Nationwide data, Boxers, Beagles, and Golden Retrievers sat at the high end of relative cancer risk, while Pomeranians, Chihuahuas, and French Bulldogs sat at the low end, echoing the familiar pattern that smaller dogs tend to face lower overall cancer risk. And the risk is not just higher for some breeds; it is shaped differently. Breaking the top breeds down by body system showed each carrying its own dominant threat rather than a uniform elevation, which is exactly what you would expect if inherited, breed-specific variants, not “being purebred,” were driving the numbers.
That is the practical heart of it. If you own a Golden Retriever or a Boxer, the relevant fact is your breed’s particular profile, not a blanket purebred statistic. If you own a mixed breed, you are not automatically safe; cancer remains what kills more dogs than anything else regardless of breeding, and roughly one in three will develop it, a rate that mirrors humans.
What to actually do with this
The reframe is not abstract; it points to different actions than “adopt a mutt and relax.”
If you already share your home with a higher-risk breed, the move is early detection. Know your dog’s normal, run your hands over them regularly and note any new lump, and keep up with routine vet visits, because caught early, many canine cancers are far more treatable. Ask your vet specifically what your breed tends to develop, since a Golden’s spleen and a Beagle’s skin are not the same watch list.
On the lifestyle side, the American Kennel Club points to the levers you can pull: limit exposure to cigarette smoke, toxic chemicals, and excessive sun, and keep your dog at a healthy weight. These genuinely help, and the AKC is candid that genetics remains the main driver, which is why breed-specific vigilance beats generic worry.
And if you are still choosing a dog, the better question is not “purebred or mixed” but “what is this specific dog’s likely health profile, and am I ready for it?” A mixed breed from a shelter is a wonderful choice for many reasons. Lower cancer risk, on the current evidence, is not the reliable one people assume it to be.
References
- Nationwide: Some High, Some Low: Purebred Cancer Rates You Need to Know
- UC Davis: Purebred Dogs Not Always at Higher Risk for Genetic Disorders, Study Finds
- Dobson, J. M. Breed-Predispositions to Cancer in Pedigree Dogs. ISRN Veterinary Science, 2013.
- American Kennel Club: How to Help Your Dog Avoid Cancer
